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Abstract
Percutaneous coronary interventions (PCIs) are nonsurgical procedures to open
blocked blood vessels to the heart, frequently using a catheter to place a stent. The
catheter can be inserted into the blood vessels using an artery in the groin or an artery
in the wrist. Because clinical trials have indicated that access via the wrist may result
in fewer post procedure complications, shortening the length of stay, and ultimately
cost less than groin access, adoption of access via the wrist has been encouraged.
However, patients treated in usual care are likely to differ from those participating
in clinical trials, and there is reason to believe that the effectiveness of wrist access
may differ between males and females. Moreover, the choice of artery access strategy
is likely to be influenced by patient or physician unmeasured factors. To study the
effectiveness of the two artery access site strategies on hospitalization charges, we use
data from a state-mandated clinical registry including 7,963 patients undergoing PCI.
A hierarchical Bayesian likelihood-based instrumental variable analysis under a latent
index modeling framework is introduced to jointly model outcomes and treatment sta-
tus. Our approach accounts for unobserved heterogeneity via a latent factor structure,
and permits nonparametric error distributions with Dirichlet process mixture models.
Our results demonstrate that artery access in the wrist reduces hospitalization charges
compared to access in the groin, with a higher mean reduction for male patients.
Keywords: Selection bias, Dirichlet process mixture priors, Heterogeneous treatment effects,
Radial versus femoral arterial access, PCI, Hospitalization charges
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1. WHICH ARTERY ACCESS SITE TO USE?
A percutaneous coronary intervention (PCI) is a nonsurgical procedure that uses a catheter
(thin flexible tube) to place a small structure, usually a stent, in the blocked blood vessels
that have been narrowed by plaque buildup. The catheter could be inserted into the blood
vessels either via an artery in the groin (a femoral artery), or via an artery in the wrist (a
radial artery). There are over one million PCIs performed each year in the United States,
predominantly using femoral arterial access (Feldman et al., 2013, Bader et al., 2017). Early
complications after a PCI include bleeding from the arterial access site as well as vascular
complications such as blood transfusions, hemorrhagic stroke, and cerebrovascular accidents.
Randomized controlled trials (RCTs) have indicated that these complications occur less
frequently after radial arterial access compared to femoral arterial access PCI (Ferrante et al.,
2016), and these fewer complications may likely lead to lower hospitalization charges (Safley
et al., 2013, Amin et al., 2013). However, such differences in hospitalization charges and in
complications between the arterial access sites have not been well-studied in an observational
setting where patients and physicians are likely to differ from those in RCTs.
There are many methodological challenges when comparing the effectiveness of radial and
femoral arterial access strategies in observational data. First, healthier patients are often
selected to undergo radial arterial access PCI, thus introducing selection bias (Rao et al.,
2008). It is, however, almost impossible to have complete measurements for all the health
indicators that could have contributed to a physician’s decision to perform a radial rather
than a femoral arterial access PCI. Second, RCTs that have studied the effectiveness of the
two access strategies also reported evidence of treatment effect heterogeneity (Rao et al.,
Submitted to Journal of the American Statistical Association
1 WHICH ARTERY ACCESS SITE TO USE?
2008). For instance, female patients tend to have fewer bleeding and vascular complications
with radial arterial access versus femoral arterial access, compared to male patients. With
the recent push to encourage adoption of radial arterial access PCI (Feldman et al., 2013),
it is important to understand the comparative effectiveness of the two arterial access site
strategies in observational settings. To do so, we make use of a state-mandated clinical
registry coordinated by the Massachusetts Data Analysis Center (Mass-DAC) for 7,963 adults
undergoing PCI (Mauri et al., 2008a). Our goal is to estimate heterogeneous access site effects
based on sex of patients in observational data where there is also selection bias.
To compare the effectiveness of radial and femoral arterial access strategies in obser-
vational data, we investigate likelihood-based estimators for instrumental variable analysis
using a latent index model framework (Heckman and Vytlacil, 1999, Vytlacil, 2002). Under
this framework, model assumptions are jointly specified on treatment and potential out-
comes. Necessary assumptions along with sensitivity analysis for the assumptions to make
a valid causal inference based on such estimators are assessed. Our focus is on a Bayesian
latent factor approach, which is a nonparametric extension of the approach proposed by
Heckman et al. (2014), to make posterior inference on the estimates of causal effects, with
particular emphasis in settings where there is treatment effect heterogeneity. Our approach
has several practical advantages over earlier approaches. It provides a framework to model
complex latent structures and account for non homogeneous correlation structures that stan-
dard parametric approaches do not. We do not rely on parametric distribution of errors.
Further, Bayesian methodology is used to estimate and make posterior inference on causal
parameters for which analytical estimates can be intractable. Simulations are developed to
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characterize operating characteristics of various estimators. Finally, we implement our ap-
proach to study heterogeneous treatment effects of radial arterial access compared to femoral
arterial access PCI on hospitalization charges based on sex of the patients.
The organization of the paper is as follows. We introduce the data and provide back-
ground literature for latent index models in Section 2. We then introduce our proposed
approach using a nonparametric Bayesian model in the context of latent index modeling
with latent factors, along with parameter estimation and derivation of treatment effects in
Section 3. We evaluate the performance of the proposed approach via simulation studies in
Section 4 and illustrate our strategy using the PCI data in Section 5. We end with discussion
in Section 6.
2. BACKGROUND
2.1 Data and Outcomes
The state-mandated clinical registry coordinated by the Mass-DAC (Mauri et al., 2008a) in-
cludes all PCIs performed in all nonfederal acute care Massachusetts hospitals for patients at
least 18 years of age, regardless of health insurance status. The registry data are populated
by trained data managers at each hospital. Baseline covariates include demographic infor-
mation, such as age, sex, race, types of health insurance; comorbidities and family history
of cardiac problems; cardiac presentation prior to the PCI, such as ejection fraction, cardiac
shock, acute coronary syndrome status; procedure-specific information, such as number of
treated vessels, degree of blockage, artery access strategy, type of stent inserted; in-hospital
complications; discharge medications; and survival status. The registry data are linked to
the Massachusetts Acute Hospital Case-Mix billing data maintained by the Massachusetts
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Center for Health Information and Analysis to obtain additional post-discharge hospitaliza-
tion information, such as subsequent admissions for PCI, bypass surgery, heart attack, etc.
Information is linked using criteria based on combinations of treatment hospital, medical
record number, admission or discharge date, and date of birth. Vital status is determined
using the Massachusetts Registry of Vital Statistics as well as the National Death Index.
We focus on 7,963 adults ≥ 18 years old undergoing PCI in 2011. Patients who resided
outside Massachusetts (to ensure completeness of 30-day follow-up) and those who were
deemed to be of exceptional risk, defined as patients having high-risk features not captured
by any variable in the data or cases where PCI offered the best or only option for improving
the chance of survival, are excluded. Because patients can undergo more than one PCI
during a hospitalization, the first or index PCI during the hospitalization is analyzed (see
Supplemental Material for a complete list of covariates).
The main endpoint of interest is the health care (procedure-related) charges at hospital
discharge. This is defined as the sum of full, undiscounted charges for patient care sum-
marized by prescribed revenue codes for special care, routine accommodation, and ancillary
services. Total charges do not include charges for telephone service, television, or private
duty nurses. As expected, the distributions of total charges at discharge for patients with
radial and femoral arterial access PCIs are skewed (Figure 1).
Additional outcomes, including 30-day and 1-year hospitalizations for major bleeding and
in-hospital vascular complications, and a falsification outcome, target vessel revascularization
(TVR), are also considered. TVR is defined as PCI performed in a vessel treated during
the index procedure or any coronary artery bypass graft (CABG) surgery performed within
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Figure 1: Density of observed hospitalization charges for radial and femoral PCI
separately.
1-year of undergoing the index PCI. TVR is a falsification outcome because no change in
TVR is expected as a consequence of different arterial access (Mauri et al., 2008b).
Table 1 summarizes outcomes for patients with radial arterial access and femoral arterial
access PCI stratified by sex. Of the 7,963 patients who had PCI in Massachusetts dur-
ing 2011, the majority (69%) were male and only 23% involved radial arterial access PCI.
Patients who had radial arterial access PCI had overall lower mean hospitalization charges
with lower incidences of bleeding and vascular complications compared to those with femoral
arterial access. We observe a two percentage point difference in the observed incidences of
TVR between patients who had radial arterial access PCI versus femoral arterial access PCI.
The goal of this study is to estimate heterogeneous effects of the two arterial access
site strategies on hospitalization charges, by adjusting for selection bias due to unmeasured
confounding, using instrumental variable analysis. Analysis of the PCI data is described
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Males Females Overall
Arterial Access Site Radial Femoral Radial Femoral Radial Femoral
No. PCI Admissions 1,325 4,141 498 1,999 1,823 6,140
In-Hospital Outcome
Mean Total Charges, $ 48,718 53,539 49,274 51,107 48,878 52,747
Vascular Complication,% 1.4 4.0 2.8 8.4 1.7 5.4
30-day Major Bleed, % 1.6 4.0 2.6 7.2 1.8 5.0
1-Year Outcomes, %
Major Bleed 7.2 8.2 11.0 17.2 8.2 13.3
TVR 6.0 8.2 6.6 8.2 6.2 8.2
Table 1: Unadjusted mean outcomes by treatment & sex. Bleed defined by an in-
hospital admission for major bleeding.
in detail in Section 5. An instrument for the analysis can be defined based on contextual
knowledge. Validity of the instrument is assessed with sensitivity analysis using the outcomes
and baseline covariates described in this section, before proceeding to estimate treatment
effects.
2.2 Approaches to Inference in the Presence of Unmeasured Confounders
An instrumental variable (IV) analysis approach permits causal inference with a confounded
treatment assignment mechanism. An IV, or simply an instrument, is defined as a random
variable that can predict treatment, but is independent of potential outcomes conditional on
observed covariates (Angrist et al., 1996). This relationship among the (potential) outcomes
Y , treatment D, measured confounders X, instrument Z, and unmeasured confounders W
is depicted in Figure 2. Likelihood-based estimators of treatment effects in IV analysis have
been introduced in previous literature. Chib and Hamilton (2000), Carneiro et al. (2003), and
O’Malley et al. (2011) proposed bivariate probit (or joint Normal) models to simultaneously
model treatment and outcomes to estimate mean treatment effect. Heckman et al. (2014) and
Jacobi et al. (2016) investigated Bayesian latent factor models to go beyond mean treatment
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Figure 2: A directed causal graph for IV analysis. Arrow display the relationships
among the (potential) outcomes Y , treatment D, measured confounders X, instrument Z
and unmeasured confounders W .
effects and estimate distributional effects. However, the model assumptions discussed in
Heckman et al. (2014) and Jacobi et al. (2016) may be too restrictive if, for example, the
continuous outcome has a non-Normal distribution. This is the case in our application,
where densities of observed charges for the two different arterial access strategies are heavily
skewed.
An extensive literature exists on alternative methods for estimating causal effects using
IV analysis that utilize a method of moments approach within a marginal structural model
framework (Herna´n et al., 2004, Van Der Laan et al., 2007, Tan, 2010), including the two-
stage least squares estimation approach (Angrist et al., 1996, Baiocchi et al., 2014). While the
method of moments approach does not make any distributional assumptions, inference often
relies on limiting assumptions, such as constant treatment effect, for identification of causal
effects. Heterogeneous treatment effects in an IV setting is a recent field of investigation
with limited work (Basu et al., 2007, Tan, 2010, Heckman et al., 2014). Our paper adds to
this burgeoning literature.
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2.3 Latent Index Model for IV Analysis
The causal effects are defined using the potential outcome framework of Rubin (1974). Let
Di ∈ {0, 1} denote a binary treatment applied to patient i and let (Yi(0), Yi(1)) denote the
two corresponding continuous potential outcomes of patient i under each treatment status.
The stable unit treatment value assumption (SUTVA) (Rubin, 1990, Angrist et al., 1996) is
assumed such that (a) the treatment assignment of one patient does not interfere with the
outcome of another patient, and (b) radial arterial access strategy is well-defined and the
same for all patients who receive it and femoral artery access strategy is well-defined and
the same for all patients who receive it.
A latent index model for IV analysis can then be written as
D = I(D∗ > 0) where D∗ = f(Z,X) + UD
Y (0) = g0(X) + U0 and Y (1) = g1(X) + U1.
(1)
Here, D∗ is a latent continuous treatment variable, I(·) is an indicator function such that
D evaluates to one if condition D∗ > 0 is satisfied and to zero otherwise; Z is used to
denote instrumental variable(s); X denotes a matrix of observed confounders; f is a function
relating the instruments and the confounders to the latent treatment status D∗; g0 and
g1 are functions that relate confounders with potential outcomes; and UD, U0 and U1 are
corresponding errors in the model. While g0, g1 and f can be nonlinear, semiparametric,
or nonparametric functions (Chib and Greenberg, 2007), most of the existing work makes
linear, parametric assumptions (Chib and Hamilton, 2000, Heckman et al., 2014). It is
further assumed that X and Z are fixed.
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When there are unobserved confounders, treatment assignment is not ignorable, i.e., U0
and U1 are not independent of D given X. Validity of the IV analysis to identify a causal
effect, in such cases, is based on whether an instrument Z meets “exclusion restriction”
assumptions (Angrist et al., 1996) stated in Assumption 1 below.
Assumption 1 A) Probability of a treatment choice is a nontrivial function of the instru-
ment Z conditional on covariates X. B) Instrument Z is mean independent of the error
terms U0 and U1 in Equation 1, conditional on X.
The implication of Assumption 1 is that there is no direct effect of the instrument on the
outcome. The instrument Z affects the potential outcomes (Y (1), Y (0)) only through its
effect on the treatment D.
In the latent index model (Equation 1), there is also an implicit assumption of mono-
tonicity (Angrist et al., 1996, Vytlacil, 2002, Tan, 2006) as stated in Assumption 2 below.
Assumption 2 Let Z = Z(ω) be a vector of instruments and Dz = Dz(ω) be the treatment
status that would be observed if Z(ω) were externally set to z. For any two levels of instru-
ment z and z
′
and vector of confounders x, monotonicity is defined as either Dz(ω) ≥ D′z(ω)
for all ω ∈ {X = x} or Dz(ω) ≤ D′z(ω) for all ω ∈ {X = x}.
Assumptions 1 and 2 are required to estimate average treatment effects under various con-
ditions in a frequentist setting (Abadie, 2002, Basu et al., 2007). Earlier work on Bayesian
methodologies for estimating average treatment effects of interventions with selection bias
have assumed Normal error distribution for potential outcome models, and very few are con-
cerned with estimating heterogeneous treatment effects (Chib and Hamilton, 2000, Hirano
et al., 2000, Heckman et al., 2014, Jacobi et al., 2016, Choi and O’Malley, 2017).
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The variance-covariance matrix of the error terms in Equation 1 is given by
COV

UD
U1
U0
 =

σ2D ρD1σ1 ρD0σ0
ρD1σ1 σ
2
1 ρ10σ1σ0
ρD0σ0 ρ10σ1σ0 σ
2
0
 ,
where, σ2D is the variance in treatment equation, σ
2
1 and σ
2
0 are the variances of the potential
outcomes Y (1) and Y (0) respectively, and ρD1 is the covariance between the treatment D
and Y (1), and so on. Thus, the latent index model in Equation 1 also assumes that the
variance-covariance matrix is homogeneous for everyone in the sample. This assumption
of homogeneous variance can be unrealistic when the underlying treatment selection might
vary by different patient subgroups, such as patients treated in different locations and hospi-
tals. Additionally, if the parameter of interest is an average treatment effect, the covariance
parameter between the potential outcomes, ρ10, is usually assumed to be zero (Chib and
Hamilton, 2000, O’Malley et al., 2011, Choi and O’Malley, 2017). However, for estimating
effects that are dependent on estimating distribution of Yi(1)− Yi(0), or some functionals of
it, such as identifying fractions of a population that benefit from a given treatment, these
approaches are inadequate. The correlation between Y (1) and Y (0) needs to be accounted
for (Heckman et al., 2014), but because Yi(1) and Yi(0) are not observed for the same patient
i, additional assumptions are necessary to identify ρ10. A latent factor structure is utilized
in Section 3 to address these shortcomings.
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To account for heterogeneous variance in the selection process of the latent index model
presented in Equation 1, we extend the work of Heckman et al. (2014) on Bayesian models for
continuous potential outcomes with a latent factor structure, and introduce a nonparametric
residual Bayesian latent factors model. The latent index model with a latent factor structure
can be written as
D = I(D∗ > 0) where D∗ = β0D + γZ + βDX + αDΘ + D
Y (1) = β01 + β1X + α1Θ + 1 and Y (0) = β
0
0 + β0X + α0Θ + 0.
(2)
The parameters γ, βD, β1 and β0 are regression coefficients; Θ is a matrix of latent factors
that explain the unobserved heterogeneity in the potential outcomes and the treatment
selection models, such that Y (1), Y (0) and D are assumed to be independent conditional
on Θ; and αD, α1 and α0 are corresponding factor loadings for the treatment model and
potential outcomes models, respectively.
All the dependence between the unobservables in the model is driven by the latent factor
Θ. By restricting Θ to be of low dimension, the covariance matrix of the error term is
fully identified by the latent structure of the model (Heckman et al., 2014). We can use the
latent representation to understand the correlation structure between potential outcomes
and treatment assignments in the proposed model. First note that
COV(pr(D = 1), Y (1)) = COV(β0D + γZ + βDX + αDΘ + D, β
0
1 + β1X + α1Θ + 1)
= αDα1Variance(Θ),
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where the last equality follows because Z is independent of Y (1) from Assumption 1 (ex-
clusion restriction) and the assumption that D and 1 are independent. Similarly, it can be
shown that COV(pr(D = 1), Y (0)) = αDα0Variance(Θ), and COV(Y (1), Y (0)) = α1α0Variance(Θ);
Variance(UD) = α
T
DVariance(Θ)αD+1,Variance(U1) = α
T
DVariance(Θ)αD+σ
2
1, and Variance(U0) =
αTDVariance(Θ)αD + σ
2
0.
The nonparametric residual assumption relies on utilizing Dirichlet process mixture
(DPM) priors (Ferguson, 1973) on 1 and 0, to build a new flexible method for under-
standing the heterogeneity and permitting dependence between the treatment D and the
continuous potential outcomes Y (1) and Y (0). We refer to our proposed extension as the
DPM latent index variable (LIV) model. The DPM prior on the errors, d for d ∈ {0, 1}, of
potential outcome under each treatment status d for patient i in the DPM LIV model can
be written as
d,i ∼ Normal(µd,i, σ2d,i)
(µd,i, σ
2
d,i)|P ∼ P = Dirichlet Process(cd, G0)
≡ P ∼ P∞ s.t. P∞(.) =
∞∑
j=1
Pjδj(.),
(3)
where, cd is a concentration parameter for treatment status d, G0 is a base distribution
and δj(.) is a Dirac delta function. The last line in Equation 3 suggests that a Dirichlet
process can also be seen as an infinite-dimensional generalization of Dirichlet distribution
and is a conjugate prior for infinite, nonparametric discrete distributions. We use conjugate
Normal(ω, τ) as a base distribution G0. Further prior specifications for the DPM process
are described in Subsection 3.1. It is assumed that the errors D, 1 and 0 are jointly
independent, and Variance(D) = 1, Variance(1) = σ
2
1 <∞, Variance(0) = σ20 <∞ .
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Heckman et al. (2014) assume the errors 1 and 0 in the potential outcome models have
symmetric Normal distributions. This specification can further introduce bias and estimation
uncertainty if the underlying densities of Y (1) and Y (0) are more complicated with many
modes or thick tails (Marra et al., 2016). Our implementation of a DPM LIV model makes
a less restrictive assumption on the distribution of error and addresses the issues of bias and
estimation uncertainty that arise from misspecification of the error distribution.
3.1 Estimation of Model Parameters
Metropolis Hastings within a Gibbs Markov Chain Monte Carlo (MCMC) algorithm is used
to sample from the posterior distribution of the parameters given observed data. The joint
posterior distribution of the model parameters, Ω, conditional on observed data can be
written as a product of likelihood and prior, P (Yobs, Dobs|X,Z,Ω) × Π(Ω). The likelihood
part of the product in the joint posterior can be factorized as
P (Yobs|Dobs, X, Z,Ω)P (Dobs|X,Z,Ω)
=
∏
i∈{Di=1}
P (Yi|Di, β01 , α1, β1,Θi, Xi, Zi, µ1,i, σ21,i)
∏
i∈{Di=0}
P (Yi|Di, β00 , α0, β0,Θi, Xi, Zi, µ0,i, σ20,i)
n∏
i=1
P (Di = 1|β0D, γ, αD, βD,Θ, Xi, Zi)
=
∏
i∈{Di=1}
P (Yi(1)|β01 , α1, β1,Θi, Xi, µ1,i, σ21,i)
∏
i∈{Di=0}
P (Yi(0)|β00 , α0, β0,Θ, Xi, µ0,i, σ20,i)
n∏
i=1
P (Di = 1|β0D, γ, αD, βD,Θ, Xi, Zi),
(4)
where, µ1 and σ
2
1 are vectors of means and variances on the errors of Y (1), and µ0, σ
2
0 are
vectors of means and variances on the errors of Y (0) respectively. A combination of condi-
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tional independence and exclusion restriction assumptions is used to express the likelihood of
observed data in terms of potential outcomes in Equation 4. For computational convenience
and (statistical) identification we assume E(0) = E(1) = E(D) = 0. This assumption is
equivalent to fitting the latent index model without an intercept and assuming DPM priors
on the parameters of the error distribution for potential outcomes. Because we we have
binary treatments, without loss of generality, we can fix the variance of UD (or equivalently
σ2D) to 1.
We assume a Normal(0, 1) prior on Θ, and non-informative Normal priors on the coeffi-
cients in the outcome models and treatment models. Additionally, the Inverse-Wishart(Ψ, ν)
hyper-prior is used on the variance τ of the DPM prior such that E(τ) = Ψ
−1
(ν−1) and Normal-
Inverse Gamma hyper-prior on the mean ω of the DPM prior. A Gamma(a,b) prior is em-
ployed on the concentration parameter c. The latent factor Θ, the parameters of the outcome
models, and the parameters of the treatment model are sequentially updated using Gibbs
sampling. The parameters of the DPM model priors are updated using the stick breaking
model of Ishwaran and James (2001). The R package DPpackage (Jara et al., 2011) is imple-
mented within our sampler to sample from the Dirichlet process mixture model and hence
our prior representation for DPM prior is consistent with the convention in the package. The
R-code for implementing the MCMC algorithm is publicly available in GitHub repositories,
as an R-package in https://github.com/SamAdhikari/BayesIV_0.1 and corresponding
simulation study in https://github.com/SamAdhikari/BayesIV_Simulations.
It is useful to observe that Θ enters the likelihood of the potential outcomes via both the
mean and the variance, such that E(Yi(0)) = E(Xiβ1 + α0Θi + µ0,i) and Variance(Yi(0)) =
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Variance(α0Θi) + σ
2
0,i. We can derive similar formulae for E(Yi(1)) and Variance(Yi(1)).
Thus, the αs and Θ can only be identified jointly as a product. For identification, the prior
variance of Θ is constrained by fixing the variance of Normal distribution at 1. Another
identification issue arises in estimating the signs of the latent factor Θ and the factor loading
αk, for k ∈ {0, 1, D}, because the likelihood in Equation 4 only depends on the sign of the
product αkΘ. The nonidentifiability of the sign is accounted for in the sampling scheme by
random sign switch.
3.2 Treatment Effects in Bayesian DPM LIV Model
We define different sample version of causal effects by averaging the outcome gain, ∆i ≡
Yi(1)− Yi(0), below. The average treatment effect (ATE) for a given set of covariates is de-
fined as, ATE(x) = E(∆|X = x) = ∫ ∆p(∆|X = x)d∆. The covariate specific heterogeneity,
which is of interest in our application, can be studied by summarizing E(Y (1)−Y (0)|Xl = x)
for groups at specific levels of a covariate (or covariates) Xl of interest, and is referred to as
the conditional average treatment effect (CATE). Finally, the average treatment effect on the
treated (ATT) for a given set of covariates can be defined as, ATT(z, x) = E(∆|D = 1, Z =
z,X = x) =
∫
∆p(∆|D = 1, Z = z,X = x)d∆. Our Bayesian approach also permits estima-
tion of the probability of benefitting (PB) from the treatment conditional on the covariates
as, PB(x) = Pr(Y (1) > Y (0)|X) = 1 − Pr(Y (1) − Y (0) < 0), using the posterior chains
from MCMC. If instead, the interest is in evaluating whether the difference in the outcomes
is greater than certain threshold, we can redefine PB(x) by replacing 0 with the threshold.
When there are heterogeneous treatment effects, the ATE(x), CATE(x), and ATT(x) will
differ.
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3.3 Posterior Inference
MCMC samples from the posterior distribution of the parameters conditional on observed
outcomes, treatment, covariates and instruments can be used to obtain posterior estimates of
the causal parameters defined below. First note that the joint distribution of the treatment
and the outcomes conditional on covariate, instrument, latent factor Θ and set of model
parameters Ω is

D∗i
Yi(1)
Yi(0)
 |Θi, Xi, Zi,Ω ∼ Normal


γZi + βDXi + αDΘi
β1Xi + α1Θi + E(1,i)
β0Xi + α0Θi + E(0,i)
 ,

1 0 0
0 Var(1,i) 0
0 0 Var(0,i)

 .
When the ith unit is observed for the treatment status D = d, E(d,i) = µd,i, and Var(d,i) =
Variance(d,i) = σ
2
d,i, else E(d,i) = µˆd,i, and Variance(i1) = σˆ
2
d,i. Second, the unconditional
joint density of (D∗, Y (1), Y (0)) can be computed by marginalizing the latent variable Θ as
P (D∗, Y (1), Y (0)|X,Z) =
∫
P (D∗, Y (1), Y (0)|Θ, X, Z)p(Θ)d(Θ)
∝
∫ ∏
i
P (D∗i |Θi, Xi, Zi)
∏
i∈{Di=1}
P (Yi(1)|Θi, Xi, µ1,i, σ21,i)∏
i∈{Di=0}
P (Yi(0)|Θi, Xi, µ0,i, σ20,i)p(Θ)d(Θ)
=
∫ ∏
i
P (D∗i |Θi, Xi, Zi)
∏
i∈{Di=1}
P (Yi|Θi, Xi, µ1,i, σ21,i)∏
i∈{Di=0}
P (Yi|Θi, Xi, µ0,i, σ20,i)p(Θ)d(Θ).
Thus, the integral can be approximated using the Monte Carlo samples from P (D∗, Yobs|Θ, X, Z,Ω)
with observed data via MCMC, when the assumptions of the DPM LIV model are met. The
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posterior estimate of an average treatment effect can then be computed as
ÂTE(x) = E(E(∆|X, θ,Ω))
≈ E( 1
M
M∑
m=1
[(Xβm1 + α
m
1 θ
m + E(1))− (Xβm0 + αm0 θm + E(0)])
=
1
n
n∑
i=1
(
1
M
M∑
m=1
[(Xiβ
m
1 + α
m
1 θ
m
i + µ¯
m
1 )− (Xiβm0 + αm0 θmi + µ¯m0 )]),
for MCMC samples m = 1, . . . ,M , number of observed data points n and set of model pa-
rameters Ω, with µ¯m1 =
1
k
∑
k∈{Di=1} µ
m
k1 and µ¯
m
0 =
1
k
∑
k∈{Di=0} µ
m
k0 . Similarly, the posterior
estimate of an average treatment effect on the treated is given by
ÂTT(z, x) =
∫ ∫
E(∆|x, θ,Ω)Pr(D = 1|Θ, x, z,Ω)p(Θ|Ω)
Pr(D = 1|x, z,Ω) p(Ω)dΘdΩ
≈ 1
M
M∑
m=1
E(∆|x,Θm,Ωm)Pr(D = 1|Θ
m, x, z,Ωm)
Pr(D = 1|x, z,Ωm)
=
1
M
M∑
m=1
E(∆|x,Θm,Ωm) Pr(D = 1|Θ
m, x, z,Ωm)
1
L
∑L
l=1 Pr(D = 1|x, z,Θl,Ωm)
.
For the proposed model,
Pr(Di = 1|Xi, Zi,Θi,Ω) = Pr(D∗i > 0) = Pr(Ziγ + αDΘi +XiβD + Di > 0)
= Pr(Di < (Ziγ + αDΘi +XiβD)) = Φ(Ziγ + αDΘi +XiβD),
and Pr(D = 1|X,Z,Θ,Ω) = 1
n
∑n
i=1 Φ(Ziγ+αDΘi +XiβD), by the linearity of expectation.
Finally, the probability that the difference in outcome is greater than threshold H can be
estimated as P̂B(x) = 1
M
∑m
m=1 Pr(Y (1) − Y (0) > H|X,Θ(m),Ω(m)), and by noting that
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Y (1) ⊥ Y (0)|Θ.
4. SIMULATION STUDY
We explore the performance of our proposed model, comparing it to an existing Bayesian
model, the latent factor model with Normal noise (Normal LIV) (Heckman et al., 2014), and
a non-Bayesian model, the two-stage least squares (2SLS) (Angrist et al., 1996) method, via
simulations. Continuous potential outcomes with binary treatment and a binary instrument
similar to our application are considered. The data generation process follows Equation
2. The matrix of covariates, X, is simulated with three columns such that X1 and X2 are
continuous and X3 is binary. Additionally, β
0
0 is fixed at 90, β0 is fixed at {−0.5, 1.5, 0}, β01
is fixed at 100, β1 is fixed at {−0.5, 1.5, 10}, β0D is fixed at -0.5, and βD is fixed at {0, 0, 1}.
Θ is generated from Normal(0, s) distribution, with s = {0.1, 0.5, 1,√10, 10} as different
considerations for standard deviations. These parameters are chosen so that the simulated
data imitate our data application with respect to the skewed distribution of the outcome
model along with a heterogeneous treatment effect based on covariate X3. Approximately
30% of the patients are treated in the simulation setting to reflect the proportion undergoing
radial artery access in our PCI cohort.
The distribution of the errors in potential outcomes, 0 and 1, is varied to quantify
the effect of different error models on the estimates of the ATE and CATE. The error of
the treatment model, D, is simulated from Normal(0, 1). The data are simulated under
both weak and strong instruments as measured by the coefficient γ, and different correla-
tion coefficients as specified by coefficients α0, α1 and αD. Below, we present results from
the simulations where the errors of the potential outcomes 0 and 1 are generated from
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Gamma(shape=3, rate=1/10), distributions with strong instrument (γ = 1.5), α0 = 0.1,
α1 = 0.1 and αD = 0.2, and Θ ∼ Normal(0, 0.1). Finally, Yobs = DY + (1−D)Y is used for
fitting the model and estimating treatment effects. Results for the remaining conditions are
shown in the Supplemental Material.
Data are simulated under varying sample sizes n. For each n, we generate and fit the
data for 50 replications. Relatively non informative prior of Normal(0, 100) is used on
the coefficients in outcome and treatment models. The latent factor Θ is assumed to have
Normal(0, 1) prior distribution for identification and the hyperpriors on the stick breaking
formulation of the DPM priors are specified as c ∼ Gamma(a, b) with a = 1, b = 1, τ ∼
InverseWishart(ν,Ψ) with ν = 1 and Ψ−1 = 5, ω ∼ Normal(m,K), m ∼ Normal(0, 1) and
K ∼ InverseGamma(1, 10). For each fit, 20,000 MCMC samples were drawn with burn in of
5,000 and every 10th draw retained for inference. Mean bias, mean width of the posterior 95%
credible interval, and percentage coverage of 95% posterior credible intervals were computed
for ATE and CATE, as defined in Section 3.2. The simulation results are reported in Table
15.
Sensitivity analysis for the hyper priors on the concentration parameter c and variance τ
on DPM priors is further conducted to investigate whether and to what degree the estimates
from the proposed model are sensitive to the prior assumptions. We use simulated data
with n = 2000, strong IV, and various specifications of the hyper parameters. Results, as
shown in the Supplemental Material, suggest that bias and 95% credible interval width of
the estimated treatment effects are agnostic to different hyper prior assumptions. However,
we observe some variation on the percentage coverage of 95% posterior credible intervals for
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Causal Absolute 95% Credible Interval
Parameter n Method Bias Width % Coverage
ATE 100 DPMLIV 2.9 18.4 98
(true = 14) NormalLIV 3.1 26.6 100
2SLS 5.4 30.1 98
500 DPMLIV 1.4 9.2 100
NormalLIV 1.6 13.5 100
2SLS 2.9 16.9 96
2000 DPMLIV 0.8 4.5 98
NormalLIV 0.9 7.4 100
2SLS 1.9 8.7 96
CATE(X3 = 1) 100 DPMLIV 3.0 21.3 100
(true = 18) NormalLIV 4.2 36.3 100
2SLS 5.8 33.8 96
500 DPMLIV 1.8 10.7 98
NormalLIV 3.5 17.1 96
2SLS 5.6 26.8 92
2000 DPMLIV 0.8 5.4 100
NormalLIV 1.8 9.6 100
2SLS 2.7 12.1 98
Table 2: Mean absolute bias, mean width of posterior 95% credible interval and
coverage of 95% credible interval of estimated average treatment effect (ATE)
and conditional average treatment effect (CATE(X3 = 1)) under Gamma(3, 0.1)
errors. Results for varying sample sizes for three different methods. True value of β00 is
fixed at 90, β0 is fixed at {−0.5, 1.5, 0}, β01 is fixed at 100, β1 is fixed at {−0.5, 1.5, 10}, β0D
is fixed at -0.5, βD is fixed at {0, 0, 1}, and Θ is generated from Normal(0, 0.1) distribution.
The errors 0 and 1 are generated from Gamma(3, 0.1) distributions; γ = 1.5; α0 = 0.1,
α1 = 0.1 and αD = 0.2.
the hyper parameter for τ .
From these simulations, we observe that incorporating DPM priors on the errors of the
potential outcome models decreases overall bias and width of the the credible interval when
estimating the ATE and CATE, particularly when the errors of the potential outcome deviate
from the Normal distribution. Thus, among the different models considered, the DPM LIV
performs the best, even when the underlying errors have Normal symmetric distribution (as
demonstrated by the simulations in the Supplemental Material). The performance of the
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widely used 2SLS method improves with increases in sample size and the strength of the
instrument while computing the ATE. But the practical use of the 2SLS remains limited
because we do not have a way to compute the CATE without stratifying the samples and
fitting different models on each sample.
5. DATA ANALYSIS
5.1 Availability of a Valid Instrument and Sensitivity Analysis
Our choice of an IV is motivated by prior experience of physicians performing radial arterial
access PCI. Radial arterial access PCI is a relatively new procedure with a steep learning
curve for physicians (Ball et al., 2011). Physicians who have traditionally performed femoral
arterial arterial access PCI are less likely to perform a radial approach (Ball et al., 2011).
Figure 3 shows a scatter plot of number of radial and femoral arterial access PCIs performed
by the physicians during 2010. The majority of the physicians have performed femoral
arterial access PCIs only. Using this information, a binary instrument that is 1 if a physician
has any prior experience on performing radial arterial access PCI in the year 2010 and zero
otherwise, is created for use in our 2011 cohort. We observe that the patients for whom the
IV is 1 are 24% more likely to receive radial arterial access PCI than those with IV=0.
Validity of the proposed instrument is evaluated with sensitivity analysis by implementing
the tests suggested in Baiocchi et al. (2014). We first assess the strength of the IV using
an F-statistic that is computed by adding an IV to the reduced first-stage model for the
treatment, after including the measured confounders X (Bound et al., 1995, Baiocchi et al.,
2014). As a general rule F-statistic greater than 10 suggests a strong IV. By fitting the full
and reduced logistic regression in the treatment equation with and without the instrument, an
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Figure 3: Scatter plot of femoral arterial access PCI and radial arterial access PCI
performed by each physician in 2010. Dotted vertical line represents surgeons who had
not performed any radial surgery in the previous year. Any PCI that was performed by the
physicians to the right of the vertical line in the year 2010 will have an IV = 1; otherwise
the physician will have IV = 0.
F-statistic of 665 is obtained, suggesting a strong instrument. We then estimate proportion
of compliers (Ertefaie et al., 2017, Baiocchi et al., 2014) by calculating the difference of
the treatment assignment rate among subjects across the values of the IV i.e., P (D =
1|Z = 1) − P (D = 1|Z = 0). The estimated proportion of compliers in our analysis is
P (D = 1|Z = 1) − P (D = 1|Z = 0) = 0.298 − 0.055 = 0.243, indicating a reasonable
effective sample size (Ertefaie et al., 2017).
Next, the exclusion restriction assumption made in Assumption 1 is assessed. Recall that
the 1-year TVR rate should be unaffected by the treatment choice of radial or femoral arterial
access PCI. As Baiocchi et al. (2014) suggest, if an IV is not associated with a treatment-
unaffected outcome, we are more confident that the exclusion restriction assumption holds.
The differences in TVR at different levels of IV, for overall sample and when stratified by
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sex is less than 1%, as shown in Table 3, suggesting that the assumption may hold in our
analysis.
Males Females Overall
Radial PCI in 2010 None > 1 None > 1 None > 1
No. PCI Admissions 1,563 3,903 716 1,781 2,279 5,684
Radial PCI in 2011 % 5.8 32.1 4.5 27.5 5.5 29.8
In-Hospital Outcomes
Mean Total Charges, $ 52,790 52,205 50,0311 50,915 52,011 51,798
Vascular Complications, % 2.8 2.5 6.6 6.3 4.8 4.5
30-Day Major Bleed, % 2.7 2.5 3.8 5.5 3.9 4.4
1-Year Outcomes, %
Major Bleed 7.9 7.6 12.2 12.9 12.5 12.1
TVR 6.8 6.9 6.9 7.4 7.2 7.9
Table 3: Treatment and unadjusted mean outcomes stratified by IV & sex. Bleed
defined by an in-hospital admission for major bleeding.
The independence assumption of the IV and unmeasured confounders cannot be con-
firmed using observed data. However, examination of the balance of measured covariates
between values of the IV may provide insight about the validity of this assumption (Ertefaie
et al., 2017, Baiocchi et al., 2014). We report the balance of measured covariates between
the levels of the IV in the Supplemental Material and observe that the confounders are fairly
balanced in our application.
5.2 Model Estimation and Results
The DPM LIV model from Equations 2 and 3 is fitted on the observed data to compare
the effectiveness of radial arterial access compared to femoral arterial access PCI in re-
ducing hospitalization charges at discharge. Relatively noninformative prior of Normal(0,
100) is used on the coefficients in outcome and treatment models. The latent factor Θ is
assumed to have Normal(0, 1) prior distribution for identification and the hyperpriors on
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the stick breaking formulation of the DPM priors are specified as c ∼ Gamma(a, b) and
τ ∼ InverseWishart(ν,Ψ). We conducted sensitivity analysis using both informative and
noninformative prior specifications on c and τ . The results from the sensitivity analysis are
reported in the Supplemental Material. The estimated posterior median of each treatment
effect with different prior specifications are within $100 of each other, with very small dif-
ference on the posterior 95% credible intervals. The sensitivity analysis suggests that our
findings are robust to the hyper-parameter specifications on the DPM priors.
To illustrate our findings, we continue with the assumption that a = 1, b = 10, ν = 2
and ψ−1 = 50. Ten thousand MCMC samples were drawn, and after 2,000 burn in and 10
thinning we retain an effective sample size of 800. Convergence of the chains was confirmed
by assessing trace plots and ensuring that the Gelman-Rubin statistics (Gelman et al., 2014)
were below 1.1. The estimated posterior median along with 95% credible interval around
the median of the treatment effects are reported in Table 7. The threshold H for estimating
the PB(x) is specified as 10% of the median overall observed charges ($41,387). Plots of the
posterior distribution of the treatment effects are shown in the Supplemental Material.
Estimated Treatment Effect Posterior Median 95% Credible Interval
ATE -$3,849 (-$5,099, -$2,632)
CATE, Female -$2,815 (-$4,211, -$1,458)
CATE, Male -$4,321 (-$5,664, -$3,003)
ATT, Radial -$3,841 (-$5,158, -$2,665)
PB 0.41 (0.38, 0.44)
Table 4: Posterior estimates of causal effects in the PCI data. Estimates of the
average treatment effect (ATE), sex specific average treatment effects (CATE, Female and
CATE, Male), and the average treatment effect on the treated (ATT) of the difference in
hospitalization charges of radial and femoral arterial access PCI reported. The estimated
probability that the difference in charges between femoral and radial arterial access PCI is
greater than H, i.e. Pr(Charges Femoral − Radial > H ), or simply PB also shown. Here,
H= 10% of median observed charges = 4,139.
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Radial arterial access PCI reduces the overall hospitalization charges compared to femoral
arterial access PCI with a mean reduction of around $3,850. Furthermore, the reduction is
about $1,500 more in male patients compared to the charges for female patients. Estimated
ATE between radial and femoral arterial access PCI is -$2,815 in female patients compared
to -$4,321 in male patients. The estimated ATT for radial arterial access PCI is similar to
the estimated ATE. The posterior 95% credible interval for the ATT is wider and overlaps
with that of the overall ATE. Finally, the estimated probability that the difference in charges
for femoral and radial arterial access PCI exceeds 10% of the median observed charges is
41%, further supporting our finding that radial arterial access is more effective in reducing
hospitalization charges compared to femoral arterial access.
Our results suggest evidence of heterogeneity in the effects of radial arterial access com-
pared to femoral arterial access PCI on hospitalization charges, based on sex of the patients.
However, the heterogeneity in the treatment group compared to the overall sample is not
very pronounced. Compared to the unadjusted difference in charges, the estimated difference
in average charges for women is considerably higher after accounting for confounders and
adjusting for unobserved confounders using IV analysis. The overall ATE after adjusting for
the instrument is higher than that estimated by only adjusting for observed confounders.
6. DISCUSSION
In this paper, we studied heterogeneous treatment effects of different arterial access site
strategies for PCI in reducing procedure related hospitalization charges at discharge, and
proposed a novel Bayesian method to extend existing methodology for estimating treatment
effects, when there is selection bias. Our new method relaxes assumptions of Normal errors
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in outcome models and homogeneous selection in treatment models that are often made in
latent index variable models. Simulations established that our method performs better than
existing methods and has reasonable frequentist properties.
Our overall finding is that radial arterial access PCI reduces hospitalization charges com-
pared to femoral arterial access PCI. This finding is to some extent consistent with that
of RCTs conducted previously, which have found that radial arterial access PCI is better
than femoral arterial access PCI in reducing major bleeding and in-hospital complications.
However, our additional finding about the heterogeneous effects in male patients and female
patients for hospitalization charges at discharge after PCI is novel. We found a reduction in
charges after radial arterial access compared to femoral arterial access PCI to be higher for
male patients than for female patients. This finding of differences in charges based on sex
and different arterial access PCIs is in some way contrary to the findings in RCTs, which
have shown that the radial arterial access PCI is more effective in female patients compared
to male patients. We have an interesting result which certainly requires further investigation
from practitioners and cardiac health researchers.
Methodologically, there are many directions to expand on the proposed work. While the
main focus of this paper is on continuous outcomes, our work can be extended to other types
of outcomes using generalized linear models. Our results assume linear relationship between
the outcome and the covariates. There are many situations when this assumption of linearity
might not hold. It will be important to explore methods that extend such restriction in the
latent index modeling framework. We have also largely ignored the hierarchical structure
of the data where the procedures are nested within hospitals. It is essential to expand our
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work to account for such hierarchical structures. Further, we rely on many assumptions to
make causal inference. Some of these assumptions are either testable or can be verified by
sensitivity analysis as shown in this paper. However, there are assumptions that cannot be
empirically tested or verified. It will be important to expand this work to include sensitivity
analysis for such assumptions.
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Figure 4: Overlaid barplots of absolute mean standardized differences between, i.) patients
with different arterial access PCIs (in grey), ii.) patients at different levels of instruments (in
red), for each observed confounder. Note that the mean standardized difference is usually
larger when comparing confounders between radial and femoral arterial access PCI com-
pared to that between different levels of the instrument, implying that the covariates are
more balanced at different levels of instruments. CAD = coronary artery disease; MI =
myocardial infarction; HF = heart failure; CABG = coronary artery bypass grafting; CVD
= cerebrovascular disease; PAD = peripheral artery diseaseLAD = left anterior descending;
STEMI = ST-Elevated Myocardial infarction.
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Figure 5: Posterior chain of different treatment effects considered in the study. Posterior
mean is represented by the horizontal solid red line, where as the 95% credible interval region
is represented by the dotted red lines.
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Covariates Radial Femoral
(n = 1,823) (n=6,140)
Demographics,%
†Mean Age, yrs 63.91 65.96
Caucasian 92 92
Male 74 70
Government Health Insurance 46 51
Comorbidities, %
Past or Current Smoker 25 24
Hypertension 77 79
Current Dialysis 1 2
Diabetes 32 32
Chronic Lung Disease 13 14
Dyslipidemia 82 83
Family History
Coronary Artery Disease 32 29
Prior Myocardial Infarction 24 28
Prior Heart Failure 8 12
Prior PCI 28 29
Prior CABG 8 15
Prior Cerebrovascular Disease 9 10
Prior Peripheral Artery Disease 11 12
Peripheral Vascular Disease 5 5
Congestive Heart Failure 10 14
Cardiac Presentation, %
Cardiogenic Shock 1 3
Elective Status 31 28
Urgent Status 52 46
Emergent or Salvage Status 16 26
Left Main Disease 4 7
LAD Artery Stenosis > 70% 57 61
Unstable Angina 35 29
Stable Angina 16 17
Non-STEMI 26 23
STEMI 15 24
Table 5: Baseline covariates that were adjusted for in the analysis for radial and femoral
PCI. Note that the patients receiving radial arterial access PCI have less severe conditions
compared to those receiving femoral arterial access PCI, hence adding to the evidence that
healthier patients usually get radial arterial access PCI. † mean age reported; CABG =
coronary artery bypass grafting; LAD = left anterior descending; STEMI = ST-Elevated
Myocardial infarction.
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Covariates (IV = 0) ( IV = 1)
(n=2,279) (n=5,684)
Demographics, %
†Mean Age, yrs 65.31 65.56
Caucasian 94 91
Male 71 70
Government Health Insurance 51 50
Comorbidities, %
Past or Current Smoker 25 24
Hypertension 80 78
Dyslipidemia 84 82
Family History
Coronary Artery Disease 32 29
Prior Myocardial Infarction 26 28
Prior Heart Failure 10 11
Prior PCI 29 29
Prior CABG 13 13
Prior Cerebrovascular Disease 10 10
Prior Peripheral Artery Disease 12 12
Current Dialysis 2 2
Diabetes 30 33
Chronic Lung Disease 13 14
Peripheral Vascular Disease 4 5
Congestive Heart Failure 12 14
Cardiac Presentation, %
Cardiogenic Shock 3 2
Elective Status 30 28
Urgent Status 45 49
Emergent or Salvage Status 26 23
Left Main Disease 6 6
LAD Artery Stenosis > 70% 60 60
Unstable Angina 28 32
Stable Angina 18 16
Non-STEMI 22 24
STEMI 24 21
Table 6: Baseline covariates at different levels of instrument to investigate the independence
assumption of the IV and unmeasured confounders. We observe that the confounders are
fairly balanced, suggesting that the assumption of the independence of the IV and unmea-
sured confounders is valid.† mean age reported; CABG = coronary artery bypass grafting;
LAD = left anterior descending; STEMI = ST-Elevated Myocardial infarction.
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Hyperparameters Treatment Effect Posterior Median 95% Credible Interval
(a,b) = (10,1) & ATE -$3,849 (-$5,099, -$2,632)
(Ψ−1, ν) = (50,2) CATE, Female -$2,815 (-$4,211, -$1,458)
CATE, Male -$4,321 (-$5,664, -$3,003)
ATT, Radial -$3,841 (-$5,158, -$2,665)
PB 0.41 (0.38, 0.44)
(a,b) = (10,1) & ATE -$3,895 (-$5,081, -$2,758)
(Ψ−1, ν) = (1,4) CATE, Female -$2,949 (-$4,268, -$1,598)
CATE, Male -$4,310 (-$5,574, -$3,136)
ATT, Radial -$3,887 (-$5,103, -$2,678)
PB 0.41 (0.37, 0.44)
(a,b) = (1,1) & ATE -$3,910 (-$5,309, -$2,629)
(Ψ−1, ν) = (50,2) CATE, Female -$2,830 (-$4,312, -$1,394)
CATE, Male -$4,379 (-$5,797, -$3,116)
ATT, Radial -$3,890 (-$5,309, -$2,575)
PB 0.41 (0.38, 0.44)
(a,b) = (1,1) & ATE -$3,856 (-$5,136, -$2,696)
(Ψ−1, ν) = (1,4) CATE, Female -$2,947 (-$4,436, -$1,635)
CATE, Male -$4,321 (-$5,544, -$3,105)
ATT, Radial -$3,842 (-$5,184, -$2,711)
PB 0.41 (0.38, 0.44)
Table 7: Sensitivity Analysis: Posterior estimates of causal effects in the PCI
data under varying hyperprior specifications on c ∼ Gamma(a, b) and τ ∼
InverseWishart(Ψ−1, ν). Estimates of the average treatment effect (ATE), sex specific
average treatment effects (CATE, Female and CATE, Male), and the average treatment ef-
fect on the treated (ATT) of the difference in hospitalization charges of radial and femoral
arterial access PCI reported. The estimated probability that the difference in charges be-
tween femoral and radial arterial access PCI is greater than H, i.e. Pr(Charges Femoral −
Radial > H ), or simply PB also shown. Here, H= 10% of median observed charges = 4,139.
Hyperparameters (a, b) and (Ψ−1, ν) are presented in the order of being noninformative to
informative.
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Causal Absolute 95% Credible Interval
Parameter Method Bias Width % Coverage
ATE DPMLIV 0.07 0.45 100
(true = 15) NormalLIV 0.07 0.49 100
2SLS 0.29 2.34 100
CATE(X3 = 1) DPMLIV 0.07 0.51 98
(true = 20) NormalLIV 0.03 0.62 100
2SLS 0.12 0.68 100
Table 8: Simulation results under Normal outcome errors. Mean absolute bias, mean
width of posterior 95% credible interval and coverage of 95% credible interval of estimated
ATE and CATE for n = 2000. True value of β00 is fixed at 90, β0 is fixed at {−0.5, 1.5, 0},
β01 is fixed at 100, β1 is fixed at {−0.5, 1.5, 10}, βD is fixed at {0, 0, 1} and Θ is generated
from Normal(0,0.1) distribution; errors on the potential outcomes 1 and 0 are generated
from Normal (0,0.5) distributions with strong instrument (γ=1.5), and α0 = 0.1, α1 = 0.1
and αD = 0.2.
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Absolute 95% Credible Interval
n γ Method Bias Width % Coverage
100 0.5 DPMLIV 0.5 10 100
NormalLIV 1.2 9 100
2SLS 2.0 31 100
500 DPMLIV 0.6 2.0 100
NormalLIV 0.7 2.7 100
2SLS 3.0 12.5 100
2000 DPMLIV 0.1 1.1 100
NormalLIV 0.1 1.4 100
2SLS 0.9 5 100
100 1.5 DPMLIV 0.5 5.0 100
NormalLIV 1.0 6.3 100
2SLS 1.7 9.8 100
500 DPMLIV 0.7 1.9 98
NormalLIV 0.8 2.4 96
2SLS 2.3 4.2 18
2000 DPMLIV 0.1 0.6 96
NormalLIV 0.1 0.9 100
2SLS 0.2 1.6 100
Table 9: Simulation result under mixture normal outcome errors: ATE. Mean
absolute bias, mean width of posterior 95% credible interval, and coverage of 95% credible
interval of estimated ATE under weak and strong instruments and varying sample sizes for
three different methods. True value of β00 is fixed at 90, β0 is fixed at {−0.5, 1.5, 0}, β01
is fixed at 100, β1 is fixed at {−0.5, 1.5, 10}, βD is fixed at {0, 0, 1}; Θ is generated from
Normal(0,0.1) distribution; α1 = 0.01, α0 = 0.01, αD = 0.01; 1 and 0 are generated from a
4-component mixture of Normal distributions with weights w = (0.15, 0.4, 0.25, 0.05), mean
parameter vector µ = (−0.1, 1, 1, 10), and variance vector v = (0.01, 0.1, 0.1, 10); true ATE
is 14.
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Absolute 95% Credible Interval
n γ Method Bias Width % Coverage
100 0.5 DPMLIV 0.27 8.6 100
NormalLIV 0.75 5.4 100
2SLS 4.67 38.5 100
500 DPMLIV 0.5 2.6 100
NormalLIV 0.4 2.3 100
2SLS 2.2 25.4 100
2000 DPMLIV 0.07 0.8 100
NormalLIV 0.15 1.6 100
2SLS 2.02 8.86 100
100 1.5 DPMLIV 0.09 1.7 100
NormalLIV 0.2 2.2 100
2SLS 1.1 5.8 100
500 DPMLIV 0.08 1.4 100
NormalLIV 0.27 1.97 100
2SLS 0.8 3.19 100
2000 DPMLIV 0.09 0.4 100
NormalLIV 0.04 0.99 100
2SLS 0.67 1.75 100
Table 10: Simulation result under mixture normal outcome errors: CATE. Mean
absolute bias, mean width of posterior 95% credible interval, and coverage of 95% credible
interval of estimated CATE (CATE|X3 = 1) under weak and strong instruments and varying
sample sizes for three different methods. True value of β00 is fixed at 90, β0 is fixed at
{−0.5, 1.5, 0}, β01 is fixed at 100, β1 is fixed at {−0.5, 1.5, 10}, βD is fixed at {0, 0, 1}; Θ
is generated from Normal(0,0.1) distribution; α1 = 0.01, α0 = 0.01, αD = 0.01; the errors
1 and 0 are generated from a 4-component mixture of Normal distributions with weights
w = (0.15, 0.4, 0.25, 0.05), mean parameter vector µ = (−0.1, 1, 1, 10), and variance vector
v = (0.01, 0.1, 0.1, 10); true CATE is 19.
Submitted to Journal of the American Statistical Association
LIST OF TABLES LIST OF TABLES
Absolute 95% Credible Interval
n γ Method Bias Width % Coverage
100 0.5 DPMLIV 0.3 11.4 100
NormalLIV 1.2 9.1 100
2SLS 1.9 31.6 100
500 DPMLIV 0.6 3.1 100
NormalLIV 0.6 2.8 100
2SLS 3.1 12.5 100
2000 DPMLIV 0.1 1.2 100
NormalLIV 0.1 1.4 100
2SLS 0.9 5 100
100 1.5 DPMLIV 0.5 6.3 100
NormalLIV 1.0 6.5 100
2SLS 1.7 9.8 100
500 DPMLIV 0.7 2.1 100
NormalLIV 0.8 2.5 100
2SLS 2.3 4.2 18
2000 DPMLIV 0.2 0.7 100
NormalLIV 0.2 0.9 100
2SLS 0.2 1.6 100
Table 11: Simulation result under mixture normal outcome errors: ATE. Mean
absolute bias, mean width of posterior 95% credible interval, and coverage of 95% credible
interval of estimated ATE under weak and strong instruments and varying sample sizes for
three different methods, with α1 = 0.1, α0 = 0.1, αD =0.2; the errors 1 and 0 are generated
from a 4-component mixture of Normal distributions with weights w = (0.15, 0.4, 0.25, 0.05),
mean parameter vector µ = (−0.1, 1, 1, 10), and variance vector v = (0.01, 0.1, 0.1, 10); true
ATE is 15.
Submitted to Journal of the American Statistical Association
LIST OF TABLES LIST OF TABLES
Absolute 95% Credible Interval
n γ Method Bias Width % Coverage
100 0.5 DPMLIV 0.7 0.6 100
NormalLIV 1.1 10.3 100
2SLS 9.1 100 100
500 DPMLIV 0.2 3.0 100
NormalLIV 0.3 3.4 100
2SLS 2.5 12.2 100
2000 DPMLIV 0.07 1.2 100
NormalLIV 0.12 1.6 100
2SLS 0.6 3.8 100
100 1.5 DPMLIV 0.3 6.2 100
NormalLIV 0.6 7.2 100
2SLS 1.6 10 100
500 DPMLIV 0.8 2.1 98
NormalLIV 1.1 3.1 100
2SLS 1.4 3.6 96
2000 DPMLIV 0.4 0.7 80
NormalLIV 0.5 1.2 70
2SLS 0.1 1.6 100
Table 12: Simulation result under mixture normal outcome errors: CATE. Mean
absolute bias, mean width of posterior 95% credible interval, and coverage of 95% credible
interval of estimated CATE (CATE|X3 = 1) under weak and strong instruments and varying
sample sizes for three different methods, with α1 = 0.1, α0 = 0.1, αD = 0.2; the errors 1
and 0 are generated from a 4-component mixture of Normal distributions with weights
w = (0.15, 0.4, 0.25, 0.05), mean parameter vector µ = (−0.1, 1, 1, 10), and variance vector
v = (0.01, 0.1, 0.1, 10); true CATE is 20.
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Causal Absolute 95% Credible Interval
Parameter s2 Method Bias Width % Coverage
ATE(true = 14) 0.25 DPMLIV 0.6 2.9 95
NormalLIV 0.8 13.3 100
2SLS 2.2 10.1 88
1 DPMLIV 0.6 2.8 93
NormalLIV 0.8 13.2 100
2SLS 1.8 10.5 98
10 DPMLIV 0.6 2.6 94
NormalLIV 0.7 14.2 100
2SLS 2.4 11.1 100
100 DPMLIV 1.4 2.3 34
NormalLIV 1.4 17.16 100
2SLS 2.8 14.1 96
CATE(X3 = 1) 0.25 DPMLIV 0.8 3.4 90
(true = 18) NormalLIV 1.2 15 100
2SLS 2.6 14 97
1 DPMLIV 0.6 3.3 92
NormalLIV 0.9 14.5 100
2SLS 2.7 14.5 98
10 DPMLIV 0.8 3.3 94
NormalLIV 1.0 15.0 100
2SLS 2.9 15.2 100
100 DPMLIV 1.3 2.9 60
NormalLIV 1.3 17.9 100
2SLS 4.8 22.7 96
Table 13: Simulation result under Gamma errors and varying variance (s2) on
Θ. Mean absolute bias, mean width of posterior 95% credible interval and coverage of 95%
credible interval of estimated average treatment effect (ATE) and conditional average treat-
ment effect (CATE(X3 = 1)) under Gamma(3,0.1) errors, n = 2000 and Θ ∼ Normal(µ, s2).
True value of β00 is fixed at 90, β0 is fixed at {−0.5, 1.5, 0}, β01 is fixed at 100, β1 is fixed at
{−0.5, 1.5, 10}, βD is fixed at {0, 0, 1}. The errors 1 and 0 are generated from Gamma(3,0.1)
distributions; γ = 1.5; α0 = 0.1, α1 = 0.1 and αD = 0.2.
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Causal Absolute 95% Credible Interval
Parameter (a, b) Method Bias Width % Coverage
ATE (0.1,1) DPMLIV 0.6 2.98 98
(true = 14) (10,1) DPMLIV 0.6 2.5 92
CATE(X3 = 1) (0.1,1) DPMLIV 0.6 3.3 94
(true = 18) (10,1) DPMLIV 0.7 2.8 92
Table 14: Sensitivity analysis with varying hyper parameters (a, b) on the Gamma
prior of the concentration parameter c for n = 2000 and strong IV: Mean absolute
bias, mean width of posterior 95% credible interval and coverage of 95% credible inter-
val of estimated average treatment effect (ATE) and conditional average treatment effect
(CATE(X3 = 1)) under Gamma(3,0.1) errors. True value of β
0
0 is fixed at 90, β0 is fixed at
{−0.5, 1.5, 0}, β01 is fixed at 100, β1 is fixed at {−0.5, 1.5, 10}, βD is fixed at {0, 0, 1}, and
Θ is generated from Normal(0,0.5) distribution. The errors 1 and 0 are generated from
Gamma(3,0.1) distributions; γ = 1.5; α0 = 0.1, α1 = 0.1 and αD = 0.2. The hyper param-
eters are presented in the increasing order of prior mean for the concentration parameter c.
Other prior specifications remain unchanged.
Causal Absolute 95% Credible Interval
Parameter (Ψ−1, ν) Method Bias Width % Coverage
ATE (1,4) DPMLIV 0.9 2.0 90
(true = 14) (0.5,4) DPMLIV 0.9 3.1 98
CATE(X3 = 1) (1,4) DPMLIV 1.1 3.5 85
(true = 18) (0.5,4) DPMLIV 1.1 3.7 85
Table 15: Sensitivity analysis with varying hyper parameters (Ψ−1, ν) on the
Inverse-Wishart prior for the variance of base distribution G0, with n = 2000
and strong IV: Mean absolute bias, mean width of posterior 95% credible interval and
coverage of 95% credible interval of estimated average treatment effect (ATE) and condi-
tional average treatment effect (CATE(X3 = 1)) under Gamma(3,0.1) errors. True value of
β00 is fixed at 90, β0 is fixed at {−0.5, 1.5, 0}, β01 is fixed at 100, β1 is fixed at {−0.5, 1.5, 10},
βD is fixed at {0, 0, 1}, and Θ is generated from Normal(0,0.5) distribution. The errors 1 and
0 are generated from Gamma(3,0.1) distributions; γ = 1.5; α0 = 0.1, α1 = 0.1 and αD = 0.2.
Hyper-parameters are presented in the increasing order of informativeness, less informative
to highly informative prior variance. Other prior specifications remain unchanged.
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